sulfonylurea vs glp 1 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Sulfonylureas in the Current Practice

Dai et al 52 found that incubating human umbilical vein endothelial cells with long-acting GLP-1 analog liraglutide was associated with an inhibition of NF-B phosphorylation and translocation from the cytoplasm to the nucleus

[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Anbari A.B., Deroche C.B., Armer J.M

Some research suggests that taking 30 minutes versus five minutes to eat leads to greater secretion of GLP-1

What began as treatments for diabetes and obesity has rapidly expanded into prevention of cardiovascular disease, slowing kidney decline, tackling liver disease, and even tentative explorations into neurodegeneration